Don't miss out on these opportunities.
Becton Dickinson (NYSE:BDX) advanced its Liverty TIPS Stent Graft for portal hypertension toward EU approval, supported by ...
Becton Dickinson (BDX) has been under pressure, with the share price showing a 0.2% decline over the past day, about 4.6% ...
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
Zacks Investment Research on MSN
BD Files for CE Mark of Liverty TIPS Stent for Portal Hypertension
Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has applied for CE Mark approval for its ...
6 analysts have shared their evaluations of Becton Dickinson (NYSE:BDX) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick ...
FRANKLIN LAKES, N.J., April 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Richard (Rick) Byrd has informed ...
BD (Becton, Dickinson and Company) announced European CE Mark approval for the Liverty transjugular intrahepatic portosystemic sh ...
Building on its established use in the United States, BD will also extend its AI-powered BD Incada™ Analytics platform to ...
Aug 7 (Reuters) - Becton Dickinson (BDX.N), opens new tab raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for ...
Shares of Becton, Dickinson and Company (NYSE:BDX) are coming back a little on Friday. This follows Thursday’s more than 18% drop. There may have been a capitulation, which could be bullish for the ...
The big dividend story with Becton, Dickinson is that it has increased its dividend annually for more than 50 years, placing it on the highly elite list of Dividend Kings. Becton, Dickinson isn't ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results